HEXO and Entourage Health Sign Long-Term Supply Agreement

Wednesday, November 16, 2022

HEXO Corp., a prominent producer of high-quality cannabis products, announced today that it has entered into a long-term supply agreement with Entourage Health Corp., a Canadian company renowned for its exceptional cannabis products.

As per the Supply Agreement, HEXO will supply bulk dried cannabis and soft gel capsules to Entourage, which will market them under its own brand portfolio. In addition, Entourage's medical marketplaces, Starseed Medicinal and Syndicate Cannabis, will now have access to HEXO-branded products such as Gems cannabis soft gels, Redebles gummies from Redecan, and select Redees premium pre-rolls. This strategic alliance will enable HEXO to better serve the needs of Canadian medical patients through Entourage's medical channels. Simultaneously, Entourage will benefit from HEXO's superior cultivation and processing capabilities by securing a consistent supply of top-quality cannabis and soft gel capsules to meet its immediate demand.

"We are delighted to collaborate with a company that shares our vision and commitment to providing Canadians with the finest cannabis products," stated Charlie Bowman, CEO of HEXO Corp. "This partnership with Entourage not only complements our expanding health and wellness portfolio, but also accelerates our business growth, allowing us to deliver premium cannabis products to a larger Canadian audience."

"Our collaboration with Entourage represents a significant milestone for HEXO in the Canadian medical market, emphasizing our dedication to meeting consumer needs and market demand," added Bowman. "We recognize the increasing potential in medicinal and therapeutic products and believe this market aligns well with our high-quality offerings."

George Scorsis, CEO and Executive Chairman of Entourage, expressed enthusiasm about the opportunities this new partnership with HEXO brings to the medical cannabis market. He highlighted the enhanced access for patients and consumers through the expansion of Starseed and Syndicate's medical offerings and distribution commitments. Leveraging HEXO's cultivation capabilities will enable Entourage to comprehensively serve all its markets and provide a consistent supply of premium cannabis to patients and consumers. The long-term wholesale supply commitment from HEXO ensures that Entourage is well-positioned to meet the growing demand for its branded products while optimizing operational efficiency.

Harvard Medical School - Leadership in Medicine Southeast Asia47th IHF World Hospital CongressHealthcare Innovation & Transformation SummitHealthcare CNO SummitHealthcare CMO SummitThe Healthcare Patient Experience & Engagement Summit 2024